Treu Jesse I (CIK 0001013425)

Latest company ownership

Role: Director
Shares held
2,763,294
Last filed at
Sep 12, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4
Shares held
2,216,935
Last filed at
Mar 24, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4
Role: 10% Owner
Shares held
286,983
Last filed at
Jul 1, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Role: 10% Owner
Shares held
187,500
Last filed at
Aug 8, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
Role: 10% Owner
Shares held
10,328
Last filed at
May 27, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
2,827
Last filed at
Dec 10, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Shares held
2,505
Last filed at
Aug 27, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
Shares held
2,311
Last filed at
Jun 11, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 6, 2019 Aug 8, 2019 Vyome Holdings, Inc 10% Owner Buy 100.0 +250,000 44.37% $1M
Mar 26, 2019 Mar 28, 2019 Aldeyra Therapeutics, Inc. Director Sell 20.0 -96,743 -4.88% $968.4K
Feb 28, 2019 Mar 4, 2019 VERACYTE, INC. Director Sell 15.0 -1,052,151 -46.00% $21.4M
Aug 23, 2018 Aug 27, 2018 Vyome Holdings, Inc 10% Owner Buy 100.0 +1,648,359 41.35% $3M
Aug 23, 2018 Aug 27, 2018 Bionano Genomics, Inc. 10% Owner Buy 82.5 +15,000 1.61% $91.9K
Jul 31, 2018 Aug 2, 2018 VERACYTE, INC. Director Sell 16.3 -500,000 -17.94% $5.4M
May 16, 2017 May 18, 2017 VERACYTE, INC. Director Sell 36.3 -24,188 -0.86% $18K
May 26, 2016 May 27, 2016 Evoke Pharma Inc 10% Owner Sell 26.3 -5,880 -36.28% $27.6K
May 26, 2016 May 27, 2016 Evoke Pharma Inc 10% Owner Sell 17.5 -344,120 -36.21% $1.6M
Apr 25, 2016 Apr 27, 2016 Evoke Pharma Inc 10% Owner Sell 37.5 -82 -0.50% $415.4
Apr 25, 2016 Apr 27, 2016 Evoke Pharma Inc 10% Owner Sell 36.3 -5,095 -0.53% $25.8K
Apr 19, 2016 Apr 21, 2016 Evoke Pharma Inc 10% Owner Sell 27.5 -708 -4.17% $3.8K
Apr 19, 2016 Apr 21, 2016 Evoke Pharma Inc 10% Owner Sell 22.5 -41,478 -4.16% $222K
Apr 11, 2016 Apr 13, 2016 Evoke Pharma Inc 10% Owner Sell 45.0 -75 -0.44% $391.5
Apr 11, 2016 Apr 13, 2016 Evoke Pharma Inc 10% Owner Sell 43.8 -4,348 -0.43% $22.7K
Apr 6, 2016 Apr 8, 2016 Evoke Pharma Inc 10% Owner Sell 27.5 -874 -4.87% $4.6K
Apr 6, 2016 Apr 8, 2016 Evoke Pharma Inc 10% Owner Sell 20.0 -51,004 -4.85% $269.2K
Aug 18, 2015 Aug 20, 2015 Evoke Pharma Inc 10% Owner Sell 27.5 -202 -1.11% $1.4K
Aug 18, 2015 Aug 20, 2015 Evoke Pharma Inc 10% Owner Sell 22.5 -11,836 -1.11% $83.1K
Jun 30, 2015 Jul 1, 2015 GLAUKOS Corp 10% Owner Sell 40.0 -8,700 -0.42% $156.6K
Apr 14, 2015 Apr 16, 2015 Evoke Pharma Inc 10% Owner Sell 20.0 -50,163 -4.50% $365.7K
Apr 14, 2015 Apr 16, 2015 Evoke Pharma Inc 10% Owner Sell 27.5 -857 -4.51% $6.2K
Nov 25, 2014 Dec 10, 2014 Evofem Biosciences, Inc. 10% Owner Sell 26.3 -2,683 -2.75% $37.6K
Nov 25, 2014 Dec 10, 2014 Evofem Biosciences, Inc. 10% Owner Sell 27.5 -87,317 -0.95% $1.2M
Nov 25, 2014 Nov 26, 2014 Evofem Biosciences, Inc. 10% Owner Sell 26.3 -2,683 -2.75% $37.6K
Nov 25, 2014 Nov 26, 2014 Evofem Biosciences, Inc. 10% Owner Sell 27.5 -87,317 -0.95% $1.2M
Oct 21, 2014 Oct 21, 2014 Esperion Therapeutics, Inc. 10% Owner Buy 100.0 +500,000 24.19% $10M
May 1, 2014 May 5, 2014 Aldeyra Therapeutics, Inc. Director Sell 20.0 -78,126 -1.97% $625K
Jul 1, 2013 Jul 2, 2013 Esperion Therapeutics, Inc. 10% Owner Buy 100.0 +285,714 15.73% $4M